Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Hematology Analyzers and Reagents Market to Reach USD 8.8 Billion by 2029 | MarketsandMarkets™


News provided by

MarketsandMarkets

14 Aug, 2024, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, Aug. 14, 2024 /PRNewswire/ -- The global hematology analyzers and reagents market is expected to grow from USD 6.6 billion in 2024 to USD 8.8 billion by 2029, at a CAGR of 6.1%, driven by advancements in technology, an increase in blood disorder incidences, and the integration of flow cytometry with hematology analyzers. Key market drivers include rising technological innovations, such as new high-throughput platforms and fully automated systems by companies like HORIBA and Siemens Healthineers. However, growth is restrained by high costs and the slow adoption of advanced instruments in emerging economies, compounded by a shortage of skilled professionals. Opportunities for expansion exist in emerging markets with improving healthcare infrastructure and rising expenditures. North America leads the market due to high demand for blood components, while the Asia-Pacific region is anticipated to experience the most significant growth. Major players include Sysmex, Danaher, and Siemens Healthineers, with recent developments focusing on new product launches and partnerships.

This image opens in the lightbox
MarketsandMarkets

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146

Browse in-depth TOC on "Hematology Analyzers and Reagents Market"

282 - Tables
59 - Figures
308 - Pages

Market Competitiveness and Key Players

The hematology analyzers and reagents market is moderately competitive, with both established and emerging players vying for market share. Major companies in this sector as of 2023 include Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden Corporation (Japan), Siemens Healthineers (Germany), Abbott Laboratories (US), Boule Diagnostics AB (Sweden), Horiba, Ltd. (Japan), Bio-Rad Laboratories Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and F. Hoffmann-La Roche Ltd. (Switzerland). Key strategies employed by these companies include new product launches, partnerships, and expansions.

Sysmex Corporation (Japan)

Sysmex Corporation is a leading player in the hematology market, specializing in the development and manufacture of analyzers and reagents for hematology and hemostasis solutions. The company operates in over 40 countries and exports to more than 190 nations. Sysmex's strategy focuses on expanding its product portfolio through new product introductions and enhancements, alongside collaborations to boost R&D and raise global awareness of its offerings.

Danaher Corporation (US)

Danaher Corporation is a major stakeholder in the hematology analyzers and reagents market, known for its extensive range of blood analysis products. The company emphasizes acquisitions and partnerships to maintain its market position and foster future growth. Danaher's focus on R&D aims to deliver innovative solutions and strengthen its competitive edge.

Abbott Laboratories (US)

Abbott Laboratories is recognized for its innovative approach in the hematology field, concentrating on product launches within its Core Laboratory segment. The company's strategy centers around advancing its product offerings and maintaining its leadership through technological advancements. The US remains a critical revenue source, contributing approximately 39% of Abbott's total revenue in FY 2023.

Siemens Healthineers (Germany)

Siemens Healthineers is a significant market player known for integrating advanced technology, including artificial intelligence (AI), into its hematology analyzers. The company offers a comprehensive range of products designed to deliver accurate, reliable, and swift results, crucial for effective patient care. Siemens Healthineers benefits from a strong global presence and extensive distribution network.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

Mindray is a prominent competitor in the hematology analyzers and reagents market, recognized for its advanced automation and user-friendly interfaces. The company operates a robust distribution and service network, with subsidiaries in over 32 countries, supporting its global sales in 190 countries. Mindray also emphasizes strong customer support and training programs to ensure effective use of its products.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146

Product and Service Segmentation

The market for hematology analyzers and reagents is divided into hematology, hemostasis, and immunohematology products and services. Hematology products and services are expected to lead the market, driven by the increasing adoption of the "reagent rental" business model by providers. This trend is anticipated to support the segment's growth throughout the forecast period.

Price Range Analysis

Hematology analyzers and reagents are categorized into high-range, mid-range, and low-range price segments. Low-range analyzers are projected to dominate the market due to their cost-efficiency per sample test, which is expected to stimulate market expansion during the forecast period.

Application Segmentation

The market is also segmented by application into hemorrhagic conditions, immune system disorders, anemia, blood cancer, infectious diseases, and other categories. The hemorrhagic conditions segment is forecasted to lead the market, driven by the increased use of hematology analyzers to regularly monitor treatment effectiveness.

End-User Analysis

The hematology analyzers and reagents market includes hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes. Commercial service providers are anticipated to hold the largest market share due to the competitive advantages they offer compared to hospitals.

Geographical Insights

The market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East. The Asia-Pacific region is expected to experience significant growth, driven by a large target patient population, increased incidence of thalassemia, and the growing geriatric population in several Asia-Pacific countries.

For more information, inquire now! Inquire Now

Related Reports:

Point of Care Diagnostics Market

Clinical Chemistry Analyzers Market

Life Science Instrumentation Market

In Vitro Diagnostics Market

Stoma Care Market

Get access to the latest updates on Hematology Analyzers and Reagents Companies and Hematology Analyzers and Reagents Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Data Center Liquid Cooling Identification Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the Data Center Liquid Cooling Identification Quadrant Report 2025

360Quadrants has released its latest Data Center Liquid Cooling Startups/SMEs Companies Assessment, 2025, recognizing key players, including both...

E2E Networks Limited recognized as 'Progressive' company by MarketsandMarkets' 360Quadrants in the GPU as a Service (GPUaaS) space

E2E Networks Limited recognized as 'Progressive' company by MarketsandMarkets' 360Quadrants in the GPU as a Service (GPUaaS) space

E2E Networks Limited has been recognized as a 'Progressive' company in the global GPU as a Service (GPUaaS) space by the 360Quadrants platform,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.